Looking after your mental health during the COVID-19 lockdown
As South Africa is currently in a three-week nationwide lockdown to combat the spread of the novel coronavirus (COVID-19),...
30
COVID-19 – A message from Cipla
The world has changed significantly with the outbreak of the coronavirus (COVID-19), and the pandemic is having significant repercussions...
Cipla’s Mirren Facility Approved by SAHPRA to produce vital medicine
At a time when South Africa desperately needs some good news, Cipla’s upgraded Mirren facility will not only be...
The Cipla/ SADAG Mental Health Journalism Awards 2020
YOUR WORK HELPS TO MAKE A DIFFERENCE, SAVE A LIFE Since the inception of the South African Depression and...
South African Health Products Regulatory Authority (SAHPRA) commended for new processes
Thanks to the efforts of the South African Health Products Regulatory Authority (SAHPRA) with their Backlog clearance project which...
Cipla working to end neglect of Paediatric HIV
It’s heart-breaking to give so many treatments to a kid at the same time,” Sani Nojiyeza, mother of Mel,...
Prioritising testing and treatment in 2020
The Cipla Foundation, through its Sha’p Left initiative, provides high-quality, customised chronic medicine pick-up point facilities (PUPs) around the...
Cipla SA signs agreement for anti-psychotic drug
As part of its quest to provide access to life-saving medication and making a difference in the lives of...
The future of HIV treatment is in empowering patients
Cipla, South Africa’s third largest pharmaceutical manufacturer, hosted an HIV/AIDS workshop in Sandton on Wednesday, ahead of World AIDS...
The Medicines Patent Pool announces new licensee for HIV paediatric treatment
Geneva, 1 December 2019 — On World AIDS Day, the Medicines Patent Pool (MPP) announces a sublicence agreement with...
